A new study describes the synthesis, mechanism of action and preclinical assessment of the nanoparticle, which is loaded with a drug that activates a protein central to the efficient induction of anti-cancer immunity.
Scientists propose a novel two-dimensional nanoconfinement strategy to strongly enhance the oxygen evolution reaction activity of low-conductivity metal-organic frameworks (MOFs).
